Inventor · disambiguated record
Jie Chen
Also filed as: CHEN JIE · Chen jie-yu
44 granted patents·36 pending applications·161 citations·filing 1999–2025
97Inventor score
Files withBRISTOL MYERS SQUIBB CO20VIIV HEALTHCARE UK NO 5 LTD8BETTA PHARMACEUTICALS CO LTD7BEIGENE LTD4JANSSEN PHARMACEUTICA NV4
Top patents by PatentIndex Score
80 records- 0195US11767322B2Triazolopyridinyl compounds as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2021·Granted Sep 26, 2023·3 cites·66 claims
- 0293US10913738B2Aminotriazolopyridines as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Feb 9, 2021·7 cites·14 claims
- 0393US9527882B2Triterpenoids with HIV maturation inhibitory activityVIIV HEALTHCARE UK (NO 4) LTD·Filed 2015·Granted Dec 27, 2016·6 cites·18 claims
- 0492US8846647B2C-17 and C-3 modified triterpenoids with HIV maturation inhibitory activityREGUEIRO-REN ALICIA·Filed 2012·Granted Sep 30, 2014·19 cites·16 claims
- 0589US8754068B2Modified C-3 betulinic acid derivatives as HIV maturation inhibitorsREGUEIRO-REN ALICIA·Filed 2011·Granted Jun 17, 2014·15 cites·24 claims
- 0689US8748415B2C-28 amines of C-3 modified betulinic acid derivatives as HIV maturation inhibitorsREGUEIRO-REN ALICIA·Filed 2012·Granted Jun 10, 2014·16 cites·15 claims
- 0788US8906889B2C-3 cycloalkenyl triterpenoids with HIV maturation inhibitory activityBRISTOL MYERS SQUIBB CO·Filed 2013·Granted Dec 9, 2014·12 cites·19 claims
- 0888US8802661B2C-28 amides of modified C-3 betulinic acid derivatives as HIV maturation inhibitorsREGUEIRO-REN ALICIA·Filed 2011·Granted Aug 12, 2014·14 cites·22 claims
- 0986US10736887B2Quinoline derivative for treating gastric cancerCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2017·Granted Aug 11, 2020·3 cites·13 claims
- 1085US11084845B2C-3 and C-17 modified triterpenoids as HIV-1 inhibitorsVIIV HEALTHCARE UK NO 5 LTD·Filed 2019·Granted Aug 10, 2021·1 cites·8 claims
- 1185US7579340B2Phenylenediamine urotensin-II receptor antagonists and CCR-9 antagonistsPFIZER·Filed 2007·Granted Aug 25, 2009·4 cites·6 claims
- 1283US10421774B2C-3 and C-17 modified triterpenoids as HIV-1 inhibitorsVIIV HEALTHCARE UK NO 5 LTD·Filed 2017·Granted Sep 24, 2019·1 cites·4 claims
- 1380US7592336B2Hepatitis C virus inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2006·Granted Sep 22, 2009·4 cites·18 claims
- 1479US12110290B2Triazolopyridinyl compounds as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2023·Granted Oct 8, 2024·0 cites·14 claims
- 1579US9611259B2Substituted pyridine derivatives useful as C-FMS kinase inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2014·Granted Apr 4, 2017·3 cites·13 claims
- 1679US2025074909A1Aminotriazolopyridines as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2024·Application pending·0 cites
- 1778US2024425505A1Triazolopyridinyl compounds as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2024·Application pending·0 cites
- 1877US2023295220A1C-3 and c-17 modified triterpenoids as hiv-1 inhibitorsVIIV HEALTHCARE UK NO 5 LTD·Filed 2022·Application pending·0 cites
- 1976US10780102B2Triterpenoids with HIV maturation inhibitory activityVIIV HEALTHCARE UK NO 4 LTD·Filed 2019·Granted Sep 22, 2020·0 cites·3 claims
- 2076US6900210B2Pyridinyl, pyrimidinyl and pyrazinyl amides as potassium channel openersBRISTOL MYERS SQUIBB CO·Filed 2003·Granted May 31, 2005·7 cites·7 claims
- 2176US6831080B2Cinnamide derivatives as KCNQ potassium channel modulatorsBRISTOL MYERS SQUIBB CO·Filed 2002·Granted Dec 14, 2004·11 cites·27 claims
- 2274US7288538B2Phenylenediamine urotensin-II receptor antagonists and CCR-9 antagonistsENCYSIVE PHARMACEUTICALS INC·Filed 2004·Granted Oct 30, 2007·5 cites·7 claims
- 2373US7087609B23-(pyridinyl-piperazin-1-yl)-phenylethyl amides as potassium channel openersBRISTOL MYERS SQUIBB CO·Filed 2003·Granted Aug 8, 2006·5 cites·7 claims
- 2472US8889854B2C-17 bicyclic amines of triterpenoids with HIV maturation inhibitory activityBRISTOL MYERS SQUIBB CO·Filed 2013·Granted Nov 18, 2014·1 cites·18 claims
- 2571US11389516B2Composition comprising UNE-L domain of leucyl-tRNA synthetase as effective ingredient for augmenting muscleUNIV GACHON IND ACAD COOP FOUND·Filed 2019·Granted Jul 19, 2022·0 cites·6 claims
- 2671US2021323997A1C-3 and c-17 modified triterpenoids as hiv-1 inhibitorsVIIV HEALTHCARE UK NO 5 LTD·Filed 2021·Application pending·0 cites
- 2769US11214566B2Substituted pyridine derivatives useful as C-FMS kinase inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2020·Granted Jan 4, 2022·0 cites·12 claims
- 2869US10245275B2Triterpenoids with HIV maturation inhibitory activityVIIV HEALTHCARE UK NO 4 LTD·Filed 2017·Granted Apr 2, 2019·0 cites·4 claims
- 2967US12157733B2Aminotriazolopyridines as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2020·Granted Dec 3, 2024·0 cites·6 claims
- 3067US6737431B2Benzoxazole derivatives as novel melatonergic agentsBRISTOL MYERS SQUIBB CO·Filed 2003·Granted May 18, 2004·3 cites·10 claims
- 3167US2024116873A1Quinoline mercaptoacetate sulfonamide derivative, intermediate, pharmaceutical derivative or formulation, and preparation method and use thereforJIANGSU CHIATAI QINGJIANG PHARMACEUTICAL CO LTD·Filed 2023·Application pending·0 cites
- 3266US9034397B2Method for treating obesityUNIV TUNGHAI·Filed 2013·Granted May 19, 2015·2 cites·3 claims
- 3366US2024057615A1Biological seed-coating agent (sca) including fermentation broth obtained based on co-cultivation of trichoderma and bacillus sequentially inoculated, and preparation method thereofUNIV SHANGHAI JIAOTONG·Filed 2022·Application pending·0 cites
- 3466US2025101028A1Heterocyclic compounds, compositions thereof, and methods of treatment therewithBEIGENE LTD·Filed 2024·Application pending·0 cites
- 3566US2024262848A1Heterocyclic compounds, compositions thereof, and methods of treatment therewithBEIGENE LTD·Filed 2024·Application pending·0 cites
- 3665US2017056420A1Triterpenoids with hiv maturation inhibitory activityVIIV HEALTHCARE UK (NO 4) LTD·Filed 2016·Application pending·0 cites
- 3762US10800764B2Substituted pyridine derivatives useful as C-FMS kinase inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2018·Granted Oct 13, 2020·0 cites·10 claims
- 3861US8178699B2Modulators of CCR9 receptor and methods of use thereofANDERSON ERIC C·Filed 2008·Granted May 15, 2012·0 cites·2 claims
- 3960US10071991B2Substituted pyridine derivatives useful as c-fms kinase inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2017·Granted Sep 11, 2018·0 cites·3 claims
- 4060US2024376086A1Solid form of rho-associated protein kinase inhibitor or solvate thereof, preparation method and use thereofBEIJING TIDE PHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 4160US2025051301A1Mutant idh1 and idh2 inhibitor and application thereofBETTA PHARMACEUTICALS CO LTD·Filed 2023·Application pending·0 cites
- 4260US2025223300A1Macrocyclic compound and pharmaceutical composition and use thereofBETTA PHARMACEUTICALS CO LTD·Filed 2023·Application pending·0 cites
- 4359US11542482B2Rice serine hydroxymethyltransferase coded gene OsSHM4 mutants and application thereofUNIV NANJING AGRICULTURAL·Filed 2020·Granted Jan 3, 2023·0 cites·14 claims
- 4459US6800590B22-Pyrimidinyloxy-n-aryl-benzylamine derivatives,their processes and usesSHANGHAI INST ORGANIC CHEM·Filed 2001·Granted Oct 5, 2004·3 cites·10 claims
- 4559US2014343000A1Compositions having c-17 and c-3 modified triterpenoids with hiv maturation inhibitory activityBRISTOL MYERS SQUIBB CO·Filed 2014·Application pending·0 cites
- 4658US2024342169A1Use of ensartinib or salt thereof in treatment of disease carrying met 14 exon skipping mutationBETTA PHARMACEUTICALS CO LTD·Filed 2022·Application pending·0 cites
- 4755US12275721B2Indazole carboxamides as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2020·Granted Apr 15, 2025·0 cites·12 claims
- 4855US5994543AAntibiotic bravomicinsBRISTOL MYERS SQUIBB CO·Filed 1999·Granted Nov 30, 1999·7 cites·10 claims
- 4955US2023310596A1Drug for treating tumorCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2021·Application pending·0 cites
- 5054US2023303534A1Preparation method for novel rho-related protein kinase inhibitor and intermediate in preparation methodBEIJING TIDE PHARMACEUTICAL CO LTD·Filed 2021·Application pending·0 cites
Showing the top 50 of 80 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Jie Chen files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →